BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9812231)

  • 21. Long-term follow-up of women with atypical squamous cells of undetermined significance (ASCUS).
    Emerson RE; Puzanov A; Brunnemer C; Younger C; Cramer H
    Diagn Cytopathol; 2002 Sep; 27(3):153-7. PubMed ID: 12203862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
    O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
    JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical squamous cells of undetermined significance: A cytohistological study in a colposcopy clinic.
    Ettler HC; Joseph MG; Downing PA; Suskin NG; Wright VC
    Diagn Cytopathol; 1999 Sep; 21(3):211-6. PubMed ID: 10450110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
    Michelow PM; Hlongwane NF; Leiman G
    Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASCUS: comparative follow-up results related to previous SIL diagnosis.
    Alameda F; Fuste P; Conangla M; Gimferrer E; Soler I; Antorn MT; Persico S; Carreras R; Serrano S
    Eur J Gynaecol Oncol; 2000; 21(1):81-3. PubMed ID: 10726627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma.
    Sherman ME; Mango LJ; Kelly D; Paull G; Ludin V; Copeland C; Solomon D; Schiffman MH
    Mod Pathol; 1994 Jun; 7(5):578-81. PubMed ID: 7937724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System.
    Rosenthal DL; Acosta D; Peters RK
    Acta Cytol; 1996; 40(1):120-6. PubMed ID: 8604564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of extensive hyperkeratosis on cervical/vaginal smears.
    Williamson BA; DeFrias D; Gunn R; Tarjan G; Nayar R
    Acta Cytol; 2003; 47(5):749-52. PubMed ID: 14526673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ASCUS : SIL ratio and the reference laboratory pathologist.
    Wachtel MS; Dahm PF
    Cytopathology; 2003 Oct; 14(5):249-56. PubMed ID: 14510888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rare atypical squamous cells of undetermined significance (ASCUS): a clinically significant diagnosis?
    Hoerl HD; Roth-Cline MD; Shalkham JE; Pfister J; Stewart J; Guo Z; De Las Casas LE; Caya JG; Kurtycz DF
    Diagn Cytopathol; 2002 Jul; 27(1):5-9. PubMed ID: 12112807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Educational needs and causes of false diagnosis of atypical squamous cells of unknown significance at a university hospital.
    Kumar N; Sayed S; Moloo Z
    Afr J Reprod Health; 2011 Mar; 15(1):113-6. PubMed ID: 21987946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical squamous cells of undetermined significance. Current laboratory practices of participants in the College of American Pathologists Interlaboratory. Comparison Program in Cervicovaginal Cytology.
    Davey DD; Nielsen ML; Naryshkin S; Robb JA; Cohen T; Kline TS
    Arch Pathol Lab Med; 1996 May; 120(5):440-4. PubMed ID: 8639046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
    Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papnet-assisted, primary screening of cervico-vaginal smears.
    Duggan MA
    Eur J Gynaecol Oncol; 2000; 21(1):35-42. PubMed ID: 10726616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistency of a double PAPNET scan of cervical smears.
    Jenny J; Isenegger I; Boon ME; Husain OA
    Acta Cytol; 1997; 41(1):82-7. PubMed ID: 9022731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
    Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
    Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women.
    Keating JT; Wang HH
    Cancer; 2001 Apr; 93(2):100-5. PubMed ID: 11309774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
    Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
    Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.